Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1128189/000107997318000589/pktx_10q-093018.htm
January 2023
December 2022
March 2022
February 2022
December 2021
June 2020
April 2020
February 2020
July 2019
November 2018
Document and Entity Information | 9 Months Ended |
---|---|
Sep. 30, 2018 shares | |
Document and Entity Information [Abstract] | |
Entity Registrant Name | ProtoKinetix, Inc. |
Entity Central Index Key | 0001128189 |
Document Type | 10-Q |
Amendment Flag | false |
Document Period End Date | Sep. 30, 2018 |
Trading Symbol | pktx |
Current Fiscal Year End Date | --12-31 |
Entity Filer Category | Non-accelerated Filer |
Entity Current Reporting Status | Yes |
Entity Small Business | true |
Entity Ex Transition Period | false |
Is Entity Emerging Growth Company? | false |
Entity Common Stock, Shares Outstanding | 257,952,433 |
Document Fiscal Period Focus | Q3 |
Document Fiscal Year Focus | 2018 |
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1128189/000107997318000589/pktx_10q-093018.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Protokinetix, Inc..
Protokinetix, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
Protokinetix, Inc. provided additional information to their SEC Filing as exhibits
Ticker: PKTX
CIK: 1128189
Form Type: 10-Q Quarterly Report
Accession Number: 0001079973-18-000589
Submitted to the SEC: Fri Oct 26 2018 9:10:08 AM EST
Accepted by the SEC: Fri Oct 26 2018
Period: Sunday, September 30, 2018
Industry: Pharmaceutical Preparations